Mentions
Extended reach
Total likes
Video views
AI synopsis
Discussions underscore the importance of the study, citing its recognition with the Pfizer prize and its role in predicting treatment response, with language like 'promising marker' and 'correlates with better outcomes', which reflect a strong endorsement and curiosity about clinical relevance and future applications.
All discussions recognize the significance of HLA-DR as a predictor for chemotherapy response, showing strong consensus.
The posts are highly engaged with the topic, highlighting the clinical implications and potential for improving treatment outcomes.
Multiple messages reference the original research findings and its awards, indicating deep interest and understanding.
The emphasis on the potential for personalizing breast cancer treatment and the recognition through awards underscore the high impact of the research.
The presence of HLA-DR on T cells of patients with #breastcancer correlates with better outcome after neoadjuvant #chemotherapy https://t.co/3utFeSvFk6 #immunology #Immunotherapy
Saraiva et al 2018, ‘HLA-DR in Cytotoxic T Lymphocytes Predicts Breast Cancer Patients' Response to Neoadjuvant Chemotherapy’ was distinguished with @pfizer prize 2019.
RT @immunicom: The presence of HLA-DR on T cells of patients with #breastcancer correlates with better outcome after neoadjuvant #chemother…
RT @immunicom: The presence of HLA-DR on T cells of patients with #breastcancer correlates with better outcome after neoadjuvant #chemother…
This study highlights that HLADR expression in cytotoxic T lymphocytes is a better predictor of breast cancer response to chemotherapy than CTL presence alone. High HLADR levels correlate with improved responses and…
This video discusses the activation of cytotoxic T lymphocytes marked by HLA-DR expression as a predictor of breast cancer patients' response to neoadjuvant chemotherapy, highlighting its potential for personalized…
Saraiva et al 2018, ‘HLA-DR in Cytotoxic T Lymphocytes Predicts Breast Cancer Patients' Response to Neoadjuvant Chemotherapy’ was distinguished with @pfizer prize 2019.
RT @immunicom: The presence of HLA-DR on T cells of patients with #breastcancer correlates with better outcome after neoadjuvant #chemother…
RT @immunicom: The presence of HLA-DR on T cells of patients with #breastcancer correlates with better outcome after neoadjuvant #chemother…
RT @immunicom: The presence of HLA-DR on T cells of patients with #breastcancer correlates with better outcome after neoadjuvant #chemother…
The presence of HLA-DR on T cells of patients with #breastcancer correlates with better outcome after neoadjuvant #chemotherapy https://t.co/3utFeSvFk6 #immunology #Immunotherapy